- Home
- / ZHEJIANG STARRY PHARMACEUTICAL
ZHEJIANG STARRY PHARMACEUTICAL
Stock Price
¥9.1
2024-10-29
Market Capitalization
¥3.9 B
2024-10-29
Revenue
¥2 B
FY, 2024
ZHEJIANG STARRY PHARMACEUTICAL Summary
Company Summary
- Overview
- ZHEJIANG STARRY PHARMACEUTICAL (浙江司太立制药股份有限公) is a manufacturer and seller of pharmaceutical products. It offers cybeclamine, iodixanol, gadopentetic acid dimeglumine, iohexol hydrolysate, iohexol iodide, and other products.
- Type
- Public
- Status
- Active
- Founded
- 1997
- Website
- http://www.starrypharm.com
- Cybersecurity rating
- Sectors
Table of Contents
ZHEJIANG STARRY PHARMACEUTICAL Financials
Summary Financials
- Revenue (Q1, 2026)
- ¥706.3M
- Gross profit (Q1, 2026)
- ¥153.4M
- Net income (Q1, 2026)
- ¥20.8M
- Cash (Q1, 2026)
- ¥308.0M
- EBIT (Q1, 2026)
- ¥56.7M
- Enterprise value
- $6.6B
Footer menu
Product
- Intelligence Suite
- Supplier Intelligence Platform
- Craft Intelligence Portal
- Craft API
- Craft for Teams
- Supplier Intelligence Platform
- Craft Alerts
- Craft N-Tier Mapping
- Craft Risk Hub
- Chrome extension
Resources
© Craft.co 2026